Dobutamine MeSH Descriptor Data 2025

MeSH Heading: Dobutamine
Tree Number(s): D02.092.311.220; D02.092.471.683.410; D02.455.426.559.389.657.166.175.220
Unique ID: D004280
RDF Unique Identifier: http://id.nlm.nih.gov/mesh/D004280
Scope Note: A catecholamine derivative with specificity for BETA-1 ADRENERGIC RECEPTORS. It is commonly used as a cardiotonic agent after CARDIAC SURGERY and during DOBUTAMINE STRESS ECHOCARDIOGRAPHY.
Entry Term(s): Dobucor; Dobuject; Dobutamin Fresenius; Dobutamin Hexal; Dobutamin Solvay; Dobutamin-ratiopharm; Dobutamina Inibsa; Dobutamina Rovi; Dobutamine (+)-Isomer; Dobutamine Hydrobromide; Dobutamine Hydrochloride; Dobutamine Lactobionate; Dobutamine Phosphate (1:1) Salt, (-)-Isomer; Dobutamine Tartrate; Dobutamine Tartrate (1:1), (R-(R*,R*))-Isomer; Dobutamine Tartrate (1:1), (S-(R*,R*))-Isomer; Dobutamine, (-)-Isomer; Dobutamine, Phosphate (1:1) Salt (+)-Isomer; Dobutrex; Lilly 81929; Oxiken; Posiject
Pharm Action: Cardiotonic Agents
Sympathomimetics
Adrenergic beta-1 Receptor Agonists
Related Numbers: 0WR771DJXV; 101626-66-8; 104564-71-8; 104564-74-1; 120885-53-2; 120885-54-3; 34368-04-2; 49745-95-1; 5D1IB9AI6J; 61661-05-0; 61661-06-1; 74753-15-4; CP0YC140T9
CAS Type 1 Name: 1,2-Benzenediol, 4-(2-((3-(4-hydroxyphenyl)-1-methylpropyl)amino)ethyl)-, (+-)-
Previous Indexing: Catecholamines (1974-1975); Phenethylamines (1974-1975); Phenols (1974-1975)
Public MeSH Note: 86; was see under CATECHOLAMINES 1976-85
History Note: 86(76); was see under CATECHOLAMINES 1976-85
Date Established: 1986/01/01
Date of Entry: 1975/07/18
Revision Date: 2018/06/30

Allowable Qualifiers: administration & dosage (AD)

adverse effects (AE)

agonists (AG)

analogs & derivatives (AA)

analysis (AN)

antagonists & inhibitors (AI)

blood (BL)

cerebrospinal fluid (CF)

chemical synthesis (CS)

chemistry (CH)

classification (CL)

economics (EC)

history (HI)

immunology (IM)

isolation & purification (IP)

metabolism (ME)

pharmacokinetics (PK)

pharmacology (PD)

poisoning (PO)

radiation effects (RE)

standards (ST)

supply & distribution (SD)

therapeutic use (TU)

toxicity (TO)

urine (UR)

Organic Chemicals [D02]
- Amines [D02.092]
  - Catecholamines [D02.092.311]

Organic Chemicals [D02]
- Amines [D02.092]
  - Ethylamines [D02.092.471]
    - Phenethylamines [D02.092.471.683]

Organic Chemicals [D02]
- Hydrocarbons [D02.455]
  - Hydrocarbons, Cyclic [D02.455.426]
    - Hydrocarbons, Aromatic [D02.455.426.559]
      - Benzene Derivatives [D02.455.426.559.389]
        
        Phenols [D02.455.426.559.389.657]
        
        Catechols [D02.455.426.559.389.657.166]
        
        Catecholamines [D02.455.426.559.389.657.166.175]
        
        Dihydroxyphenylalanine [D02.455.426.559.389.657.166.175.200]
        
        Dobutamine [D02.455.426.559.389.657.166.175.220]
        
        Dopamine [D02.455.426.559.389.657.166.175.342]
        
        Epinephrine [D02.455.426.559.389.657.166.175.461]
        
        Isoproterenol [D02.455.426.559.389.657.166.175.649]
        
        Metaproterenol [D02.455.426.559.389.657.166.175.660]
        
        Norepinephrine [D02.455.426.559.389.657.166.175.830]

Dobutamine Preferred

Dobutrex Narrower

Dobutamine Tartrate Narrower

Dobutamine Lactobionate Narrower

Dobutamine Tartrate (1:1), (R-(R*,R*))-Isomer Narrower

Dobutamine Phosphate (1:1) Salt, (-)-Isomer Narrower

Dobutamine, Phosphate (1:1) Salt (+)-Isomer Narrower

Dobutamine Hydrochloride Narrower

Dobutamine (+)-Isomer Narrower

Dobutamine, (-)-Isomer Narrower

Dobutamine Hydrobromide Narrower

Lilly 81929 Narrower

Dobutamin Solvay Narrower

Dobutamin Hexal Narrower

Dobutamin Fresenius Narrower

Dobuject Narrower

Dobucor Narrower

Posiject Narrower

Oxiken Narrower

Dobutamina Rovi Narrower

Dobutamina Inibsa Narrower

Dobutamin-ratiopharm Narrower

page delivered in 0.152s